GGrantIndex
← Leaderboards

Monica Gandhi

University Of California, San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$27,077,063
Attributed
$39,562,970
Total exposure
25
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $9.8M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$69,742,486 · 26

By mechanism

P30$32,874,445 · 4
R01$24,960,145 · 8
R37$2,383,968 · 1
UG3$2,024,874 · 1
UH3$1,828,735 · 1
R25$1,755,000 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Monitor”

Research focus

MonitorParticipantPharmaceutical PreparationsResearch PersonnelAdherenceGrantSamplingInnovationPreventionCohortPlasmaBaseHairUnited States National Institutes Of HealthCommunitiesProgramsEpidemicLaboratoriesPublic Health RelevanceFundingResourcesAntiretroviral TherapyClinicAnti-Retroviral Agents

Grant awards (99)

UCSF-Bay Area Center for AIDS Research$3,146,338
P30 · FY2025 · AI · contact PI
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.$1,828,735
UH3 · FY2025 · DA
University of California, San Francisco/Kaiser Permanente Northern California Division of Research Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 Program$909,200
K12 · FY2025 · AR
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.$779,281
R37 · FY2025 · AI · contact PI
Unraveling the intersection of substance use, inflammation, and HIV via hair levels$752,599
R01 · FY2025 · DA · contact PI
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)$639,956
R01 · FY2025 · AI · contact PI
Administrative Core$449,479
P30 · FY2025 · AI · contact PI
Triaging dolutegravir resistance via a point-of-care urine tenofovir assay$438,195
R01 · FY2025 · AI · contact PI
The HIV Nexus Scholars Program: A Research Education Program for Early-Stage Investigators Working at the Intersection of Biomedical, Social/Behavioral, and Clinical Science$351,000
R25 · FY2025 · AI
Triaging dolutegravir resistance via a point-of-care urine tenofovir assay$256,688
R01 · FY2025 · AI · contact PI
Recent Advances in HIV Research$20,000
R13 · FY2025 · AI · contact PI
UCSF-Bay Area Center for AIDS Research$3,097,293
P30 · FY2024 · AI · contact PI
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.$970,487
UG3 · FY2024 · DA
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.$783,827
R37 · FY2024 · AI · contact PI
Unraveling the intersection of substance use, inflammation, and HIV via hair levels$756,284
R01 · FY2024 · DA · contact PI
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)$684,905
R01 · FY2024 · AI · contact PI
Administrative Core$499,109
P30 · FY2024 · AI · contact PI
Support of Diversity Initiatives in the UCSF-Bay Area CFAR: Developing HIV Researchers from Pipeline to Early Career Faculty$393,816
P30 · FY2024 · AI · contact PI
Support of Diversity Initiatives in the UCSF-Bay Area CFAR: Developing HIV Researchers from Pipeline to Early Career Faculty (Revision to Developmental Core)$393,816
P30 · FY2024 · AI · contact PI
The HIV Nexus Scholars Program: A Research Education Program for Early-Stage Investigators Working at the Intersection of Biomedical, Social/Behavioral, and Clinical Science$351,000
R25 · FY2024 · AI
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$326,142
R01 · FY2024 · AI
UCSF-Bay Area Center for AIDS Research$239,711
P30 · FY2024 · AI · contact PI
UCSF-Bay Area Center for AIDS Research$79,986
P30 · FY2024 · AI · contact PI
UCSF-Bay Area Center for AIDS Research$75,600
P30 · FY2024 · AI · contact PI
Recent Advances in HIV Research$20,000
R13 · FY2024 · AI · contact PI
UCSF-Bay Area Center for AIDS Research$3,579,157
P30 · FY2023 · AI · contact PI
Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.$1,054,387
UG3 · FY2023 · DA
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.$820,860
R37 · FY2023 · AI · contact PI
Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic$798,527
R01 · FY2023 · AI · contact PI
Unraveling the intersection of substance use, inflammation, and HIV via hair levels$774,688
R01 · FY2023 · DA · contact PI
Administrative Core$568,310
P30 · FY2023 · AI · contact PI
The HIV Nexus Scholars Program: A Research Education Program for Early-Stage Investigators Working at the Intersection of Biomedical, Social/Behavioral, and Clinical Science$351,000
R25 · FY2023 · AI
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$331,897
R01 · FY2023 · AI
Evaluation of the Impact of HIV Status on the Immune Response to mRNA COVID-19 Vaccines$242,250
R21 · FY2023 · AI · contact PI
UCSF-Bay Area Center for AIDS Research$210,824
P30 · FY2023 · AI · contact PI
Administrative Core$210,824
P30 · FY2023 · AI · contact PI
Recent Advances in HIV Research$20,000
R13 · FY2023 · AI · contact PI
UCSF-Bay Area Center for AIDS Research$3,613,271
P30 · FY2022 · AI · contact PI
UCSF-Bay Area Center for AIDS Research$1,197,787
P30 · FY2022 · AI · contact PI
Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic$802,565
R01 · FY2022 · AI · contact PI
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP$766,622
R01 · FY2022 · AI · contact PI
Administrative Core$573,391
P30 · FY2022 · AI · contact PI
The HIV Nexus Scholars Program: A Research Education Program for Early-Stage Investigators Working at the Intersection of Biomedical, Social/Behavioral, and Clinical Science$351,000
R25 · FY2022 · AI
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$338,904
R01 · FY2022 · AI
Evaluation of the Impact of HIV Status on the Immune Response to mRNA COVID-19 Vaccines$201,875
R21 · FY2022 · AI · contact PI
Collaborative community networks to optimize implementation of low barrier COVID-19 testing efforts among diverse Latinx populations in Northern California$3,432,455
P30 · FY2021 · AI · contact PI
UCSF-Gladstone Center for AIDS Research$3,354,700
P30 · FY2021 · AI · contact PI
Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic$799,372
R01 · FY2021 · AI · contact PI
"Hair Extensions": Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables$756,997
R01 · FY2021 · AI · contact PI
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP$676,412
R01 · FY2021 · AI · contact PI
The HIV Nexus Scholars Program: A Research Education Program for Early-Stage Investigators Working at the Intersection of Biomedical, Social/Behavioral, and Clinical Science$351,000
R25 · FY2021 · AI
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$343,910
R01 · FY2021 · AI
Objective measures of adherence for later-stage ART failure in resource limited settings$80,750
R03 · FY2021 · AI · contact PI
Recent Advances in AIDS and HIV Research$20,000
R13 · FY2021 · AI · contact PI
UCSF-Gladstone Center for AIDS Research$3,504,445
P30 · FY2020 · AI · contact PI
"Hair Extensions": Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables$759,666
R01 · FY2020 · AI · contact PI
Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic$709,784
R01 · FY2020 · AI · contact PI
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP$685,812
R01 · FY2020 · AI · contact PI
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection$670,213
R01 · FY2020 · AI
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients$601,406
R01 · FY2020 · MH
Urine tenofovir point-of-care test to identify patients in need of ART adherence support$343,464
R01 · FY2020 · AI
Objective measures of adherence for later-stage ART failure in resource limited settings$80,542
R03 · FY2020 · AI · contact PI
Recent Advances in AIDS and HIV Research$20,000
R13 · FY2020 · AI · contact PI
UCSF-Gladstone Center for AIDS Research$4,254,133
P30 · FY2019 · AI · contact PI
"Hair Extensions": Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables$747,319
R01 · FY2019 · AI · contact PI
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP$694,914
R01 · FY2019 · AI · contact PI
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection$690,151
R01 · FY2019 · AI
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients$618,728
R01 · FY2019 · MH
Acceptability and feasibility of self-collecting biological specimens among high-risk populations$196,757
R21 · FY2019 · AI
Assessing Mother and Infant Antiretroviral Exposure Using Hair Measures$157,149
R21 · FY2019 · AI
Recent Advances in AIDS and HIV Research$20,000
R13 · FY2019 · AI · contact PI
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP$745,788
R01 · FY2018 · AI · contact PI
"Hair Extensions": Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables$728,559
R01 · FY2018 · AI · contact PI
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection$696,561
R01 · FY2018 · AI
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients$603,484
R01 · FY2018 · MH
Assessing Mother and Infant Antiretroviral Exposure Using Hair Measures$301,430
R21 · FY2018 · AI
Acceptability and feasibility of self-collecting biological specimens among high-risk populations$246,912
R21 · FY2018 · AI
Recent Advances in AIDS and HIV Research$20,000
R13 · FY2018 · AI · contact PI
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection$751,593
R01 · FY2017 · AI
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients$616,778
R01 · FY2017 · MH
Hair Extensions: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables$615,646
R01 · FY2017 · AI · contact PI
Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection$765,381
R01 · FY2016 · AI
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients$646,010
R01 · FY2016 · MH
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials$385,635
R01 · FY2016 · AI · contact PI
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials$500,637
R01 · FY2015 · AI · contact PI
Hair measures to assess adherence and explain outcomes in an HIV clinical trial$153,558
R21 · FY2015 · AI · contact PI
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials$538,824
R01 · FY2014 · AI · contact PI
Hair measures to assess adherence and explain outcomes in an HIV clinical trial$189,000
R21 · FY2014 · AI · contact PI
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials$265,282
R01 · FY2013 · AI · contact PI
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials$333,847
R01 · FY2012 · AI · contact PI
Developing a Mentoring Network of Diverse Mental Health Professionals$201,859
R24 · FY2012 · MH · contact PI
Developing a Mentoring Network of Diverse Mental Health Professionals$168,767
R24 · FY2011 · MH · contact PI
Assessing antiretroviral exposure in diverse populations$121,690
K23 · FY2009 · AI · contact PI
Assessing antiretroviral exposure in diverse populations$121,690
K23 · FY2008 · AI · contact PI
Assessing antiretroviral exposure in diverse populations$121,690
K23 · FY2007 · AI · contact PI
Assessing antiretroviral exposure in diverse populations$121,690
K23 · FY2006 · AI · contact PI
Assessing antiretroviral exposure in diverse populations$121,690
K23 · FY2005 · AI
ANALYSIS OF NRTI LEVELS IN THE INTRACELLULAR COMPARTMENT, PLASMA AND HAIR IN$3,673
M01 · FY2005 · RR
NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS, COMPARTMENTS &PLASMA IN HIV+ WOMEN$33,147
M01 · FY2004 · RR